AGP Picks
View all

The Europe Sun
Provided by AGP

The Europe Sun: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 12, 2026

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
May 12, 2026

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

Indeterminate GlobeNewswire
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
May 12, 2026

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Indeterminate GlobeNewswire
Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026
May 12, 2026

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Indeterminate GlobeNewswire
InterContinental Energy’s P2(H2)Node™ integrates AI data centre for low cost, ultra-reliable green compute in Asia
May 12, 2026

InterContinental Energy’s P2(H2)Node™ integrates AI data centre for low cost, ultra-reliable green compute in Asia

Indeterminate EIN Presswire
Mexico and Brazil among most complex jurisdictions to do business in, says the 2026 GBCI
May 12, 2026

Mexico and Brazil among most complex jurisdictions to do business in, says the 2026 GBCI

Indeterminate GlobeNewswire
Robotaxi Trillion-Dollar Market; But an Unsolved Operations Problem
May 12, 2026

Robotaxi Trillion-Dollar Market; But an Unsolved Operations Problem

Indeterminate GlobeNewswire
Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026
May 12, 2026

Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026

Indeterminate GlobeNewswire
BulkQuant Launchs AI-Powered Quant Trading Platform With Fully Automated Strategies
May 12, 2026

BulkQuant Launchs AI-Powered Quant Trading Platform With Fully Automated Strategies

Indeterminate GlobeNewswire
Robin Energy Ltd. Reports Results for the Three Months Ended March 31, 2026
May 12, 2026

Robin Energy Ltd. Reports Results for the Three Months Ended March 31, 2026

Indeterminate GlobeNewswire
Flying Tiger Copenhagen Announces Entry into Canada with Initial Store Openings in the Greater Toronto Area
May 12, 2026

Flying Tiger Copenhagen Announces Entry into Canada with Initial Store Openings in the Greater Toronto Area

Indeterminate GlobeNewswire
Globex Enters Option Agreement on its Ramp/Maude Lake Gold Property in Ontario
May 12, 2026

Globex Enters Option Agreement on its Ramp/Maude Lake Gold Property in Ontario

Indeterminate GlobeNewswire
Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder
May 12, 2026

Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder

Indeterminate GlobeNewswire
New Fluke FEV500 Redefines Testing for Fast DC Electric Vehicle Chargers, Eliminating Costly Downtime
May 12, 2026

New Fluke FEV500 Redefines Testing for Fast DC Electric Vehicle Chargers, Eliminating Costly Downtime

Indeterminate GlobeNewswire
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
May 12, 2026

Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies
May 12, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies

Indeterminate GlobeNewswire
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform
May 12, 2026

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform

Indeterminate GlobeNewswire
Fusion Fuel to Release Investor Update Video and Presentation Highlighting Strategic Progress and Key Milestones for the Year Ahead
May 12, 2026

Fusion Fuel to Release Investor Update Video and Presentation Highlighting Strategic Progress and Key Milestones for the Year Ahead

Indeterminate GlobeNewswire
CRML Set to Become the Market Leader for Hafnium Production and Supply Security Taking Away China's Current 75% Market Share
May 12, 2026

CRML Set to Become the Market Leader for Hafnium Production and Supply Security Taking Away China's Current 75% Market Share

Indeterminate GlobeNewswire
Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases
May 12, 2026

Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases

Indeterminate GlobeNewswire
Brysa Warns Media Operators That Cheap AdTech Stacks Are Inflating Long-Term Costs
May 12, 2026

Brysa Warns Media Operators That Cheap AdTech Stacks Are Inflating Long-Term Costs

Indeterminate EIN Presswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Europe Sun

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.